Keywords:
zo`riqish bosh og`rig`i, Monreal shkalasi, surunkali miya ishemiyasi,assotsiyalashgan migren.References
Anttila V., Stefansson H., Kallela M., Todt U., Terwindt G.M., Calafato M.S., Nyholt D.R., Dimas A.S., Freilinger T., et al.; International Headache Genetics Consortium. Genomewide association study of migraine implicates a common susceptibility variant on 8q22.1 // Nat Genet. 2010 Oct. V.42(10). P.869–873.
Asghar M.S., Adam E. Hansen, Henrik B. W. Larsson, Jes Olesen, Messoud Ashina Effect of CGRP and sumatriptan on the BOLD response in visual cortex // J Headache Pain. 2012. V.13. P.159–166.
Asghar M.S., Hansen A.E., Amin F.M., van der Geest R.J., Koning P.V., Larsson H.B., Olesen J., Ashina M. Evidence for a vascular factor in migraine // Ann Neurol. 2011. V.69(4). P.635–645.
Ayzenberg I., Katsarava Z., Sborowski A., Chernysh M., Osipova V., Tabeeva G., Yakhno N., Steiner T.J. The prevalence of primary headache disorders in Russia: a countrywide survey // Cephalalgia. 2012. V.32. P.373–381.
Ayzenberg I., Katsarava Z., Sborowski A., Chernysh M., Osipova V., Tabeeva G., Steiner T.J. Headache–attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed // Eur J Neurol. 2014 May. V.21(5). P.758–765.
Ayzenberg I., Katsarava Z., Sborowski A., Obermann M., Chernysh M., Osipova V., Tabeeva G., Steiner T.J. Headache yesterday in Russia: its prevalence and impact, and their application in estimating the national burden attributable to headache disorders // J Headache Pain. 2015 Jan 20. V.15. P.7.
Barbanti P., Fofi L., Aurilia C., Egeo G. Dopaminergic symptoms in migraine // Neurol Sci. 2013. V.34(1). P.67–70.
De Fusco M., Marconi R., Silvestri L., et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2 // Nat Genet. 2003. V.33. P.192–196.
Dichgans M., Freilinger T., Eckstein G., et al. Mutations in the neuronal voltage–gated sodium channel SCN1A in familial hemiplegic migraine // Lancet. 2005. V.336. P.371–377.
Freilinger T., Anttila V., de Vries B., International Headache Genetics Consortium et al. Genome–wide association analysis identifies susceptibility loci for migraine without aura // Nat Genet. 2012. V. 44. P.777–782.
Freilinger T., Koch J., Dichgans M., Mamsa H., Jen J. A novel mutation in SLC1A3 associated with pure hemiplegic migraine // J Headache Pain. 2010. V.11. P.90.
Friberg L., Olesen J., Iversen H.K., Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan // Lancet. 1991. V.338(8758). P.13–17.
Geppetti P., Jay Guido Capone, Marcello Trevisani, Paola Nicoletti, Giovanni Zagli, Maria Rosalia Tola. CGRP and migraine: neurogenic inflammation revisited // J Headache Pain. 2005. V.6(2). P.61–70
Katsarava Z., Limmroth V. Is a combination of tramadol and acetaminophen effective for the treatment of acute migraine pain? // Nat Clin Pract Neurol. 2006 Jul. V.2(7). P.360–361.
Lee H., Jen J.C., Cha Y.H., Nelson S.F., Baloh R.W. Phenotypic and Genetic Analysis of a Large Family with Migraine– Associated Vertigo // Headache. 2008. V.48(10). P.1460–1467.
Lemos C., Mendonc D.¸ Pereira–Monteiro J., Barros J., Sequeiros J., Alonso I., Sousa A. BDNF and CGRP interaction: Implications in migraine susceptibility // Cephalalgia an international journal of headache. 2010. V.30(11). P.1375–1382.
Lemos C., Neto J.L., Pereira–Monteiro J. et al. A role for endothelin receptor type A in migraine without aura susceptibility? A study in Portuguese patients // Eur J Neurol. 2011. V.18. P.649–655.
Levy D. Endogenous mechanisms underlying the activation and sensitization of meningeal nociceptors: the role of immunovascular interactions and cortical spreading depression // Curr Pain Headache Rep. 2012. V.16. P.270–277.
Levy D., Burstein R. The vascular theory of migraine: leave it or love it? // Ann Neurol. 2011. V.69(4). P.600–601.
Loder E. Migraine with aura and increased risk of ischaemic stroke // BMJ. 2009 Oct 27. V.339. P.b4380
Loder E., Rizzoli P. Biomarkers in migraine: their promise, problems, and practical applications // Headache. 2006 Jul–Aug. V.46(7). P.1046–1058
Ophoff R.A., DeYoung J., Service S.K. et al. Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1–p21.3 // Am J Hum Genet. 2001. V.69. P.447–453.
Ophoff R.A., Terwindt G.M., Vergouwe M.N., et al. Familial hemiplegic migraine and episodic ataxia type–2 are caused by mutations in the Ca2+ channel gene CACNL1A4 // Cell. 1996. V.87. P.543–552
Piterobon D., Striessing J. Neurobiology of migraine // Nat Rev Neurosci. 2003. V.4(5). P.386–398
Russell M.B., Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management // Lancet Neurol. 2011. V.10. P.457–470
Russell M.B., Olesen J. Increased familial risk and evidence of genetic factor in migraine // BMJ. 1995. V.311. P.541–544.